Randomized Phase II Study of Timed Sequential Busulfan in Combination With Fludarabine in Allogeneic Stem Cell Transplantation
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 15 Jan 2018
At a glance
- Drugs Busulfan (Primary) ; Fludarabine (Primary) ; Filgrastim; Methotrexate; Tacrolimus
- Indications Acute myeloid leukaemia; Chronic lymphocytic leukaemia; Chronic myeloid leukaemia; Hodgkin's disease; Multiple myeloma; Myelodysplastic syndromes; Myeloproliferative disorders; Non-Hodgkin's lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 09 Jan 2018 Planned End Date changed from 1 Apr 2017 to 1 Apr 2019.
- 09 Jan 2018 Planned primary completion date changed from 1 Apr 2018 to 1 Apr 2019.
- 19 Dec 2016 Planned primary completion date changed from 1 Apr 2017 to 1 Apr 2018.